ClinicalTrials.govpublic full text
Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer
endometrial adenocarcinoma, endometrial adenosquamous carcinoma, endometrial clear cell adenocarcinoma, endometrial endometrioid adenocarcinoma, variant with squamous differentiation, endometrial serous adenocarcinoma, endometrioid stromal sarcoma, recurrent uterine corpus carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 891336
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.